Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Nov;61(11):968–974. doi: 10.1136/ard.61.11.968

Atopic disorders in ankylosing spondylitis and rheumatoid arthritis

M Rudwaleit 1, B Andermann 1, R Alten 1, H Sorensen 1, J Listing 1, A Zink 1, J Sieper 1, J Braun 1
PMCID: PMC1753933  PMID: 12379517

Abstract

Background: The prevalence of atopic disorders in ankylosing spondylitis (AS) is unknown. AS and rheumatoid arthritis (RA) exhibit divergent T helper (Th) cell cytokine patterns.

Objective: To test the hypothesis that Th2 polarised atopic disorders may be decreased in Th1 polarised RA but increased in AS, which is characterised by an impaired Th1 cytokine pattern, by assessing the prevalence of atopic disorders in AS and RA.

Methods: 2008 subjects (380 patients with AS, 728 patients with RA, 900 controls) from Berlin, Germany, were considered in this cross sectional study. A questionnaire incorporating questions from the European Community Respiratory Health Service (ECRHS) and the International Study of Asthma and Allergies in Childhood (ISAAC) protocol was mailed to all subjects. Disease severity was assessed by the modified Health Assessment Questionnaire (mHAQ).

Results: 1271 (63.3%) people responded to the questionnaire. The prevalence of any atopic disorder was 24.6% (61/248) in patients with AS, 20.7% (111/536) in controls, and 13.1% (64/487) in patients with RA (p=0.0009 for AS v RA; p=0.001 for controls v RA). Hay fever was reported by 40/248 (16.1%) patients with AS, 82/536 (15.3%) controls, and 42/487 (8.6%) patients with RA (p=0.002 for AS v RA; p=0.001 for controls v RA). Atopic dermatitis was reported by 19/248 (7.7%) patients with AS, 26/536 (4.9%) controls, and 14/487 (2.9%) patients with RA (p=0.003 for AS v RA), and asthma by 18/248 (7.3%) patients with AS, 35/536 (6.5%) controls, and 21/487 (4.3%) patients with RA. The differences were related neither to age nor to drugs. Disease severity was less in atopic patients with RA who had the atopic disorder before the onset of RA (median mHAQ 0.75) than in patients in whom RA preceded the atopic disorder (median mHAQ 1.75; p=0.027).

Conclusions: Atopic disorders are decreased in RA but only slightly and non-significantly increased in AS. This may imply that atopy confers some protection from RA but only little if any susceptibility to AS. It may further indicate that the cytokine deviation towards an impaired Th1 pattern in AS is less strong than the cytokine deviation towards Th1 in RA, a finding which may affect future therapeutic approaches.

Full Text

The Full Text of this article is available as a PDF (167.6 KB).

Figure 1 .

Figure 1

Open in a new tab

Prevalence (%) of any atopic disorder in controls, patients with AS, and patients with RA. The differences between AS and RA, and between controls and RA, respectively, were significant as indicated by the p value.

Figure 2 .

Figure 2

Open in a new tab

Prevalence (%) of asthma, hay fever, and atopic eczema in controls (n=536), patients with AS (n=248), and patients with RA (n=487). The differences for hay fever between AS and RA, and between controls and RA, and the difference for atopic eczema between AS and RA, respectively, were significant as indicated by the p values.

Figure 3 .

Figure 3

Open in a new tab

Prevalence of any atopic disorder in controls and in patients with RA according to age. In addition to the percentage, absolute numbers of atopic subjects are also given. A significant difference was found for the 45–54 year age group.

Figure 4 .

Figure 4

Open in a new tab

Prevalence of any atopic disorder in controls and patients with AS according to age. In addition to the percentage, absolute numbers of atopic subjects are also given.

Figure 5 .

Figure 5

Open in a new tab

Disease severity assessed by the mHAQ in atopic patients with RA who experienced the atopic disorder before the onset of RA and in atopic patients who developed RA before the onset of the atopic disorder. Horizontal bars represent the median, open boxes the 25–75th centile. The difference is significant (p=0.03).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature. 1996 Oct 31;383(6603):787–793. doi: 10.1038/383787a0. [DOI] [PubMed] [Google Scholar]
  2. Allanore Y., Hilliquin P., Coste J., Renoux M., Menkès C. J. Decreased prevalence of atopy in rheumatoid arthritis. Lancet. 1998 Feb 14;351(9101):497–497. doi: 10.1016/s0140-6736(05)78684-0. [DOI] [PubMed] [Google Scholar]
  3. Asher M. I., Keil U., Anderson H. R., Beasley R., Crane J., Martinez F., Mitchell E. A., Pearce N., Sibbald B., Stewart A. W. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995 Mar;8(3):483–491. doi: 10.1183/09031936.95.08030483. [DOI] [PubMed] [Google Scholar]
  4. Brandt J., Haibel H., Cornely D., Golder W., Gonzalez J., Reddig J., Thriene W., Sieper J., Braun J. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum. 2000 Jun;43(6):1346–1352. doi: 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  5. Braun J., Sieper J. The sacroiliac joint in the spondyloarthropathies. Curr Opin Rheumatol. 1996 Jul;8(4):275–287. doi: 10.1097/00002281-199607000-00003. [DOI] [PubMed] [Google Scholar]
  6. Burney P. G., Laitinen L. A., Perdrizet S., Huckauf H., Tattersfield A. E., Chinn S., Poisson N., Heeren A., Britton J. R., Jones T. Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J. 1989 Nov;2(10):940–945. [PubMed] [Google Scholar]
  7. Burney P. G., Luczynska C., Chinn S., Jarvis D. The European Community Respiratory Health Survey. Eur Respir J. 1994 May;7(5):954–960. doi: 10.1183/09031936.94.07050954. [DOI] [PubMed] [Google Scholar]
  8. Cañete J. D., Martínez S. E., Farrés J., Sanmartí R., Blay M., Gómez A., Salvador G., Muñoz-Gómez J. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis. 2000 Apr;59(4):263–268. doi: 10.1136/ard.59.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Decreased prevalence of atopic diseases in children with diabetes. The EURODIAB Substudy 2 Study Group. J Pediatr. 2000 Oct;137(4):470–474. doi: 10.1067/mpd.2000.109109. [DOI] [PubMed] [Google Scholar]
  10. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 1992 Oct;47(5):450–455. doi: 10.1111/j.1398-9995.1992.tb00662.x. [DOI] [PubMed] [Google Scholar]
  11. Dolhain R. J., van der Heiden A. N., ter Haar N. T., Breedveld F. C., Miltenburg A. M. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996 Dec;39(12):1961–1969. doi: 10.1002/art.1780391204. [DOI] [PubMed] [Google Scholar]
  12. Eriksson N. E., Holmen A. Skin prick tests with standardized extracts of inhalant allergens in 7099 adult patients with asthma or rhinitis: cross-sensitizations and relationships to age, sex, month of birth and year of testing. J Investig Allergol Clin Immunol. 1996 Jan-Feb;6(1):36–46. [PubMed] [Google Scholar]
  13. Gaston J. S. Will the increasing prevalence of atopy have a favourable impact on rheumatoid arthritis? Ann Rheum Dis. 1998 May;57(5):265–267. doi: 10.1136/ard.57.5.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hanneuse Y., Delespesse G., Hudson D., de Halleux F., Jacques J. M. Influence of ageing on IgE-mediated reactions in allergic patients. Clin Allergy. 1978 Mar;8(2):165–174. doi: 10.1111/j.1365-2222.1978.tb00461.x. [DOI] [PubMed] [Google Scholar]
  15. Kay A. B. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001 Jan 4;344(1):30–37. doi: 10.1056/NEJM200101043440106. [DOI] [PubMed] [Google Scholar]
  16. Liblau R. S., Singer S. M., McDevitt H. O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 1995 Jan;16(1):34–38. doi: 10.1016/0167-5699(95)80068-9. [DOI] [PubMed] [Google Scholar]
  17. Maini R. N., Taylor P. C. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med. 2000;51:207–229. doi: 10.1146/annurev.med.51.1.207. [DOI] [PubMed] [Google Scholar]
  18. McGonagle D., Gibbon W., O'Connor P., Green M., Pease C., Emery P. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum. 1998 Apr;41(4):694–700. doi: 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  19. Nelson J. L., Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am. 1997 Feb;23(1):195–212. doi: 10.1016/s0889-857x(05)70323-9. [DOI] [PubMed] [Google Scholar]
  20. Nowak D., Heinrich J., Jörres R., Wassmer G., Berger J., Beck E., Boczor S., Claussen M., Wichmann H. E., Magnussen H. Prevalence of respiratory symptoms, bronchial hyperresponsiveness and atopy among adults: west and east Germany. Eur Respir J. 1996 Dec;9(12):2541–2552. doi: 10.1183/09031936.96.09122541. [DOI] [PubMed] [Google Scholar]
  21. O'Driscoll B. R., Milburn H. J., Kemeny D. M., Cochrane G. M., Panayi G. S. Atopy and rheumatoid arthritis. Clin Allergy. 1985 Nov;15(6):547–553. doi: 10.1111/j.1365-2222.1985.tb02308.x. [DOI] [PubMed] [Google Scholar]
  22. Oro A. S., Guarino T. J., Driver R., Steinman L., Umetsu D. T. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol. 1996 Jun;97(6):1402–1408. doi: 10.1016/s0091-6749(96)70210-5. [DOI] [PubMed] [Google Scholar]
  23. Ostensen M. The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):235–237. doi: 10.1111/j.1600-0897.1992.tb00801.x. [DOI] [PubMed] [Google Scholar]
  24. Pearce N., Weiland S., Keil U., Langridge P., Anderson H. R., Strachan D., Bauman A., Young L., Gluyas P., Ruffin D. Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J. 1993 Nov;6(10):1455–1461. [PubMed] [Google Scholar]
  25. Peskett S. A., Platts-Mills T. A., Ansell B. M., Stearnes G. N. Incidence of atopy in rheumatic disease. J Rheumatol. 1981 Mar-Apr;8(2):321–324. [PubMed] [Google Scholar]
  26. Pincus T., Summey J. A., Soraci S. A., Jr, Wallston K. A., Hummon N. P. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983 Nov;26(11):1346–1353. doi: 10.1002/art.1780261107. [DOI] [PubMed] [Google Scholar]
  27. Prescott S. L., Sly P. D., Holt P. G. Raised serum IgE associated with reduced responsiveness to DPT vaccination during infancy. Lancet. 1998 May 16;351(9114):1489–1489. doi: 10.1016/S0140-6736(05)78871-1. [DOI] [PubMed] [Google Scholar]
  28. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. 1997 Oct;18(10):478–482. doi: 10.1016/s0167-5699(97)01127-4. [DOI] [PubMed] [Google Scholar]
  29. Rudwaleit M., Siegert S., Yin Z., Eick J., Thiel A., Radbruch A., Sieper J., Braun J. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis. 2001 Jan;60(1):36–42. doi: 10.1136/ard.60.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schulze-Koops H., Lipsky P. E., Kavanaugh A. F., Davis L. S. Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol. 1995 Nov 15;155(10):5029–5037. [PubMed] [Google Scholar]
  31. Shirakawa T., Enomoto T., Shimazu S., Hopkin J. M. The inverse association between tuberculin responses and atopic disorder. Science. 1997 Jan 3;275(5296):77–79. doi: 10.1126/science.275.5296.77. [DOI] [PubMed] [Google Scholar]
  32. Simon A. K., Seipelt E., Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8562–8566. doi: 10.1073/pnas.91.18.8562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Van den Bosch F., Kruithof E., Baeten D., De Keyser F., Mielants H., Veys E. M. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis. 2000 Jun;59(6):428–433. doi: 10.1136/ard.59.6.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Verhoef C. M., van Roon J. A., Vianen M. E., Bruijnzeel-Koomen C. A., Lafeber F. P., Bijlsma J. W. Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance. Ann Rheum Dis. 1998 May;57(5):275–280. doi: 10.1136/ard.57.5.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zink A., Braun J., Listing J., Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol. 2000 Mar;27(3):613–622. [PubMed] [Google Scholar]
  36. van Roon J. A., Lafeber F. P., Bijlsma J. W. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 2001 Jan;44(1):3–12. doi: 10.1002/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  37. von Mutius E., Martinez F. D., Fritzsch C., Nicolai T., Roell G., Thiemann H. H. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):358–364. doi: 10.1164/ajrccm.149.2.8306030. [DOI] [PubMed] [Google Scholar]
  38. von Mutius E., Weiland S. K., Fritzsch C., Duhme H., Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet. 1998 Mar 21;351(9106):862–866. doi: 10.1016/S0140-6736(97)10100-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES